GlassScriptPhysician profile
Tangular Michelle Barnes
NPI 1902294093
$8,740.25
in general payments reported to CMS, 2019-2025
17 companies · $222 in 2025
The $222 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,903 · 2022: $2,141 · 2023: $2,210 · 2024: $1,265 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,696.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,175.70 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,358.67 | 2021-2025 | Caplyta |
| Alkermes, INC. | $782.01 | 2021-2024 | Lybalvi, Aristada |
| Teva Pharmaceuticals USA, INC. | $715.24 | 2021-2024 | Uzedy, Austedo Xr, Austedo |
| Otsuka America Pharmaceutical, INC. | $705.61 | 2021-2024 | Abilify Maintena, Rexulti, Abilify Asimtufii |
| Neurocrine Biosciences, INC. | $593.80 | 2021-2023 | Ingrezza |
| Lundbeck LLC | $510.11 | 2021-2024 | Abilify Maintena, Abilify Asimtufii |
| Janssen Pharmaceuticals, INC | $479.41 | 2021-2024 | Invega Sustenna |
| Vanda Pharmaceuticals INC. | $398.74 | 2021-2023 | Fanapt, Hetlioz |
| Sunovion Pharmaceuticals INC. | $377.97 | 2021-2022 | |
| Indivior INC. | $281.81 | 2022-2024 | Perseris |
| Idorsia Pharmaceuticals US INC | $92.08 | 2023 | Quviviq |
| Supernus Pharmaceuticals, INC. | $89.87 | 2022-2024 | Qelbree |
| Avanir Pharmaceuticals, INC. | $69.88 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $54.55 | 2021-2023 | Trintellix |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $36.67 | 2022 | |
| Corium, LLC | $18.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tangular Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.